Health - Autism Research Institute https://autism.org/category/health/ Advancing Autism Research and Education Wed, 08 May 2024 21:09:01 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.3 Motor Skills and Executive Function in Autism https://autism.org/motor-cognitive-development/ Wed, 08 May 2024 01:07:13 +0000 https://autism.org/?p=17943 Learn about emerging research on the relationship between the development of motor skills and executive function in autistic children. Handouts are online HERE The speakers: Megan MacDonald, PhD is a professor of kinesiology, the early childhood research core director at the Hallie E. Ford

The post Motor Skills and Executive Function in Autism appeared first on Autism Research Institute.

]]>

Learn about emerging research on the relationship between the development of motor skills and executive function in autistic children.

Handouts are online HERE

The speakers:

Megan MacDonald, PhD is a professor of kinesiology, the early childhood research core director at the Hallie E. Ford Center for Children and Families and the OSU IMPACT for Life faculty scholar – all housed within the College of Health. Her vision is that every child is active and accepted.

Megan McClelland, PhD, is the Katherine E. Smith Professor of Healthy Children and Families at Oregon State University (OSU) where she serves as Endowed Director at the Hallie E. Ford Center for Healthy Children and Families. Her research focuses on optimizing children’s development, especially as it relates to children’s self-regulation, early learning, and school success. Her recent work has examined links between self-regulation and long-term outcomes from early childhood to adulthood, recent advances in measuring self-regulation, and intervention efforts to improve these skills in young children. She works with colleagues and collaborators around the world and is currently involved with a number of national and international projects to develop measures of self-regulation and improve school success in young children.

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

The post Motor Skills and Executive Function in Autism appeared first on Autism Research Institute.

]]>
White Matter Development and Language in Autism https://autism.org/white-matter/ Wed, 24 Apr 2024 00:49:59 +0000 https://autism.org/?p=17927 Learn about emerging research on white matter development and language abilities during infancy in autism.Handouts are online HERE  The speaker: Tyler McFayden, PhD, is a NICHD T32 Postdoctoral Fellow at the University of North Carolina-Chapel Hill. Prior to her T32 position, she received her bachelor's

The post White Matter Development and Language in Autism appeared first on Autism Research Institute.

]]>

Learn about emerging research on white matter development and language abilities during infancy in autism.

Handouts are online HERE 

The speaker:

Tyler McFayden, PhD, is a NICHD T32 Postdoctoral Fellow at the University of North Carolina-Chapel Hill. Prior to her T32 position, she received her bachelor’s in science from Davidson College and PhD in Developmental and Clinical Psychology from Virginia Tech. She completed her APA-accredited internship at UNC’s Carolina Institute for Developmental Disabilities. Dr. McFayden currently works with Dr. Clare Harrop (Health Sciences) and Dr. Mike O’Shea (Pediatrics), researching social communication profiles of autistic youth and sex differences in neurodevelopmental trajectories. Dr. McFayden also works closely with Dr. Jessica Girault, PhD, a member of the IBIS group at UNC, studying neuro-behavior relations in high-likelihood infant samples. The April presentation will feature results and discussions from their recent paper highlighting a novel white matter-language connection in the right arcuate fasciculus in infants who later are diagnosed with autism at 24 months.

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

The post White Matter Development and Language in Autism appeared first on Autism Research Institute.

]]>
Research Updates: Nutrition and Autism 2023 https://autism.org/research-updates-nutrition-and-autism-2023/ Tue, 17 Oct 2023 16:00:16 +0000 https://last-drum.flywheelsites.com/?p=16041 Kelly Barnhill, MBA, CN, CCN, summarizes emerging research on nutritional approaches and supports for autistic people. She outlines recent investigations on sensory processing and nutrition, dietary changes, and supplementation. The speaker discusses recent systematic reviews, highlighting general consensus and gaps in research. Barnhill describes several ongoing studies and future avenues of

The post Research Updates: Nutrition and Autism 2023 appeared first on Autism Research Institute.

]]>

Kelly Barnhill, MBA, CN, CCN, summarizes emerging research on nutritional approaches and supports for autistic people. She outlines recent investigations on sensory processing and nutrition, dietary changes, and supplementation. The speaker discusses recent systematic reviews, highlighting general consensus and gaps in research. Barnhill describes several ongoing studies and future avenues of investigation before the Q&A session.

In this webinar: 

1:30 – Goals and objectives
2:45 – Critical aspects of current discourse
5:28 – Sensory processing and diet
9:15 – Dietary changes
13:40 – Dietary supplements
14:30 – Systematic reviews and meta-analyses
19:00 – Significant findings from the last year
22:00 – Ongoing and future research
29:03 – Q&A

Current discourse and recent publications

Barnhill outlines presentation goals and objectives and highlights the challenges faced by researchers during the COVID-19 pandemic before diving into research updates (1:30).

She summarizes a study that found that 43 autistic participants had significantly higher histamine and lower thiamine than non-austic controls. The speaker asserts that these findings suggest the need for further research into potential interventions and screenings that target these biomarkers (2:45). A study on the impact of dietary quality on executive function found a correlation between poor dietary quality (high intake of processed carbohydrates) and impaired working memory, executive function, and organizational skills (3:58). Barnhill states that dietary factors impact development trajectories and that improving diet quality can improve educational outcomes (4:25)

Sensory processing and nutrition

The presenter summarizes a study that found autistic children exhibit higher sensory sensitivity to food than their non-autistic peers. Study data also showed lower levels of calcium and vitamin D in the autistic group compared to non-autistic controls. These findings, she continues, reinforce the clinical perspective of food sensitivity in autism, which also emphasizes the impact these sensitivities have on food choices and eating aversions (5:28).

Barnhill cites a study that revealed family units of individuals with food sensitivities also present with different eating profiles (6:00). Another sensory study on BMI found that almost 60% of participants met units for being overweight, and 12% met criteria for thinness or failure to thrive (7:00). These and other studies show autistic children have different eating and feeding styles than non-autistic controls. Barnhill notes that a lot of work is being done to profile how autistic children participate in feeding environments, what their preferences may look like, and appropriate interventions (8:00)

Dietary changes and supplements

Barnhill explains that a growing body of evidence supports dietary changes and vitamin supplementation in autism. A study involving 400 males and 130 females across multiple facilities in the UK tracked nutrition and development over time. Results showed that adopting a ketogenic diet, with professional support, can be a feasible and appropriate intervention for autistic children (9:15). The speaker cites a survey study that revealed no significant differences in routine while starting a ketogenic diet and that it is easy to assist children in starting the diet if necessary (11:00). Barnhill suggests screening for autism in children who present with significant feeding disorders. 

The speaker describes two animal model studies examining the effect of ketogenic diets on mouse behavior. The first study found that mice on ketogenic diets had reduced social and cognitive deficits and repetitive behaviors and an increased abundance of beneficial microbes in the gut, with no adverse side effects reported. A second study found similar results and also indicated that ketogenic diets may restore histone balances in affected mice (12:15). A third mouse model that tested zinc supplementation saw improvements in social interaction and fear but had no effect on social novelty, or the initiation of new circumstances (13:40).

Systematic reviews and meta-analyses

Barnhill presents a review that found low choline and B vitamins and abnormal amino acids in autistic children compared to non-autistic groups (14:50). Another review on probiotic supplementation found evidence that dietary change can increase oxidative stress. The presenter suggests monitoring oxidative stress as a mark of microbiome changes in the future (16:05). Clinical literature reviews assert that autistic individuals are often deficient in vitamins A, C, B6, and B12. Across reviews of gluten-free/casein-free (GF/CF) diets, there is consensus that GF/CF diets are quite feasible and carry few adverse effects (17:03). Barnhill highlights a review of dietary interventions by Amadi et al. as an excellent source for big picture concepts and detailed questions (18:23)

The speaker highlights significant studies from the last year that looked at nutrients/probiotics as anti-inflammatories/modulators (19:00), prenatal diets as a modifier for environmental risk factors for autistic traits (19:50), and assessment and data collection methods across studies (20:35). She explains that to best represent typical dietary intake, three-day real-time collection across weekdays and weekends is needed (21:22)

Ongoing and future research

Barnhill outlines an ongoing study in Florida that explores the impact of eating program interventions (22:25). She also highlights an ongoing longitudinal study assessing the effect of therapeutic GF/CF diet and physiotherapy on the gross motor and cognition of autistic children (23:18). Enrollment is currently open for another exciting study that looks at using folic acid to promote language development (24:01). Finally, the first large study on the impact of mitochondrial function and nutrient intervention is also currently being conducted (25:31). These studies, the speaker asserts, represent a continuous efforts to advance our understanding of autism and identify targeted interventions. 

Barnhill considers future avenues of research and underscores that the most significant barrier to nutritional research is a lack of funding. Contemporary research, she continues, should focus on targeted dietary intakes and anti-inflammatory factors. While GF/CF diets are feasible and effective, she warns against having tunnel vision and reminds viewers that we must always consider more than one avenue (26:30)

Q & A

During the Q&A (29:03), Barnhill discusses picky eating and nutrition in adulthood (31:40), feeding therapy and dietary changes (36:00), paleo diets and multivitamins (38:00), and Celiac and autoimmune diseases in autism (44:50). She also considers good sources for protein (51:45), vitamins (55:15), and multivitamins (57:05).

The speaker:

Kelly Barnhill, MBA, CN, CCN, is the Director of the Nutrition Clinic at The Johnson Center for Child Health and Development. She is a Certified Clinical Nutritionist, with over a decade of experience working with nutrition in children with autism and related disorders. At the Johnson Center she directs a team of dieticians and nutritionists that has served over 3000 children through this practice.

In addition to her clinical practice, Kelly also serves as the Johnson Center Clinical Care Director, overseeing management and implementation of multidisciplinary care across the practices within the organization. In 2008, Kelly accepted the position of Nutrition Coordinator for the Autism Research Institute. In this role, she designs and manages curriculum and training for hundreds of nutrition practitioners each year, as well as providing direct training for thousands of parents. Kelly is a sought-after presenter, speaking at several national and international conferences each year.

Her studies and work at JCCHD are the culmination of many years’ effort and expertise, with the last several years devoted to understanding the biological underpinnings of the disorder we know as autism. Her work has raised awareness of the need for these services for children with autism and related disorders. Kelly is a graduate of The University of Texas at Austin.

Ms. Barnhill also sits on ARI’s Board of Directors and Scientific Advisory Board.

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

  • pans/pots nutrition, autism related disorder

Food and Sleep

March 1st, 2022|Nutrition, Sleep, Ways to Help, Webinar|

Vicki Kobliner, RDN, CD-N, describes nutritional and lifestyle strategies for improving sleep and overall health for autistic people. She discusses circadian rhythm and balancing cortisol and melatonin cycles throughout the day.

The post Research Updates: Nutrition and Autism 2023 appeared first on Autism Research Institute.

]]>
Transitions from Pediatric to Adult Medical Care https://autism.org/transition-medical-care-adulthood/ Tue, 04 Oct 2022 21:49:58 +0000 https://last-drum.flywheelsites.com/?p=14602 Julie Corder, CNP, and Carrie Cuomo, DNP, CPNP, with the Cleveland Clinic Learning Hospital, discuss the critical stages of transition from pediatric to adult healthcare for individuals with complex medical needs. They define health care transitions (HCT), outline core elements for a successful HCT, and provide various resources. The presenters consider potential

The post Transitions from Pediatric to Adult Medical Care appeared first on Autism Research Institute.

]]>

Julie Corder, CNP, and Carrie Cuomo, DNP, CPNP, with the Cleveland Clinic Learning Hospital, discuss the critical stages of transition from pediatric to adult healthcare for individuals with complex medical needs. They define health care transitions (HCT), outline core elements for a successful HCT, and provide various resources. The presenters consider potential timelines and goals for different stages of HCT and discuss what turning 18 means in the US. Cuomo and Corder underscore the role that telehealth can play in HCT and share a video resource with explanations and social stories. Throughout the presentation, the speakers emphasize that it is never too late or too early to begin preparing for HCT and that transition plans are individual and different. They close with a question and answer session where they discuss insurance, COVID anxiety, social workers, and more.

Handouts are online HERE
Take the knowledge quiz for this webinar HERE

In this webinar: 

00:56 – Learning objectives
2:19 – Statistics
4:30 – Transitions as a process
8:03 – Transition vs transfer
10:13 – Got Transition resource
11:50 – Switching physicians
13:10 – Six core elements of transition
15:44 – Transition readiness questionnaire and example
17:20 – HCT Timeline and goals, 12 – 14
20:40 – HCT Timeline and goals, 14 – 16
24:27 – HCT Timeline and goals, 16 – 17
27:20 – Turning 18
29:08 – HCT Goals, 18+
30:25 – Identifying caregivers
30:38 – Example: Transition of care plan
31:27 – Example: Documents transfer
32:33 – Transition resources
36:32 – Finding an adult provider
38:23 – CARES Telehealth meet and greets
39:10 – Video: Tele-transitions and social stories
42:07 – Questions for your new care providers
44:55 – Create your goal
46:12 – Quote
47:06 – Q & A

Carrie Cuomo outlines the presentation objectives (00:56) and notes that individuals with autism do not receive health care transition services (HCTS) at the same rate as their non-autistic peers (2:09). She provides statistics on co-occurring conditions and the number of autistic youth that turn 18 every year (3:08). Cuomo defines a health care transition (HCT) as 

“… the process of moving from a child/family-centered model of health care to an adult/parent-centered model of health care, with or without transferring to a new clinician. It involves planning, transfer, and integration into adult-centered health care model (4:30).”

The speaker underscores that transitions are personal and take many years (6:17) and that it is essential to celebrate the small victories (9:20). Cuomo suggests Got Transition as a resource with various tools that can be individualized and reproduced for youth, parents, providers, and educators (10:13). She highlights that there is no wrong way to make an HCT and notes that adult providers often include management of conditions that specialists manage for children (11:00). The presenter lists the six core elements of transition as practiced in their profession: 

  1. Receive a transition policy
  2. Transition tracking and monitoring
  3. Transition readiness assessment to detect knowledge gaps and strengths
  4. Transition planning
  5. Transfer of care (where you actually change providers) 
  6. Transfer completion and feedback

Julie Corder (17:05) provides suggestions for HCT timelines and goals for individuals of different ages. She notes that the ages are simply a range and that it is never too early or too late to begin planning for HCT. The timelines and goals are summarized below.

Timeline (17:20) and HCT Goals (19:07): 12 – 14 years 

It is crucial to ask providers how long they will take care of someone and if they are prepared to assist in HCT for your teen. Caregivers can help youth learn about their own health conditions, medications, and allergies and endorse time alone with the teen and provider for part of each visit. Assistive technology (AT) devices are often used to support independence for individuals with communication difficulties and can encourage teens to ask their doctor questions about their own health. Youths should aim to communicate directly with their providers for a portion of the visit and prepare for appointments by writing down questions beforehand. 

Timeline (20:40) and HCT Goals (22:40): 14 – 16 years

Parents/guardians and teens can complete a readiness assessment and discuss it with their practitioner. Caregivers can also help youth learn more about their health, emergency management, how to order and refill prescriptions, and how to make appointments. Corder suggests encouraging teens to see their provider alone for part of each visit. Teens can aim for an ability to summarize their health history in three sentences or less to share with providers and to know medications, dosage, allergies, and routines independently. At this point, Corder suggests that teens and caregivers actively discuss HCT with each other and their providers.

Timeline (24:27) and HCT Goals (26:34): 16 – 17 years 

Youth should carry contact information for medical providers and insurance in their wallet or phone. They can learn to use patient portals and should explore shared decision-making via agencies and lawyers to determine the correct level of oversight after 18. It is best to begin searching for adult care providers and subspecialty providers at this point as well. Teens can aim to talk to the doctor independently and may want to see their provider on their own during an appointment. At this point, teens should know when and how to get emergency care and find their doctor’s phone number and contact. 

HCT Goals (29:08): 18 years

Corder suggests that once legally an adult, individuals should know how to obtain medical information from a health portal, make and cancel appointments, get to the doctor’s office, receive a referral, and generally manage their own health care and well-being. If individuals cannot do these things on their own, Corder continues, they will need to identify someone else who can assist them and has the authority to do so (30:25)

The speaker outlines what turning 18 means in the US concerning adulthood, healthcare decisions, and confidentiality. She underscores that after 18, “… your health and medical information are private (confidential) and cannot be shared unless you give the OK.” Corder provides multiple transition plan resources, examples (32:22), and tips for finding an adult provider (36:32). She discusses the positive impacts that telehealth can have on family care and HCTS and highlights the increasing use of tele-transition services (38:23). The presenters share a video clip that explains tele-transition meet and greets and supplies virtual appointment practice videos and social stories (40:10). Corder reminds viewers that healthcare transitions are challenging, emotional, and different for every person (45:01) before opening the question and answer session (47:06).

The transition from pediatric to adult healthcare is a critical stage for all individuals, and particularly so for patients with complex medical needs. Learn about the factors to consider when navigating this challenging life period.

Handouts are online HERE

The speakers:

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

Back-to-School Resources

August 22nd, 2022|News|

Whether you’re a parent preparing a child for grade school or an adult transitioning into or out of college, the back-to-school season can present unique challenges for families and individuals with autism.

LGBTQIA+ and Autism

June 13th, 2022|News, Parenting|

Contemporary research on the intersection of autism, sexuality, and gender identity asserts that autistic individuals are more likely to identify as LGBTQIA+ than the neurotypical population. Similarly, the prevalence of autism is

The post Transitions from Pediatric to Adult Medical Care appeared first on Autism Research Institute.

]]>
Plural ‘Autisms’ and the Promises of Autism Metabolomics https://autism.org/autism-metabolomics/ Tue, 16 Aug 2022 16:03:30 +0000 https://last-drum.flywheelsites.com/?p=15276 The increasing moves towards the pluralisation of autism -- ‘the autisms’ -- and the many routes to a diagnosis of autism. What studying dietary intervention for autism suggests regarding metabolomics and the bigger picture of individualised autism science. Handouts are online HERE This is a joint presentation by ARI

The post Plural ‘Autisms’ and the Promises of Autism Metabolomics appeared first on Autism Research Institute.

]]>

The increasing moves towards the pluralisation of autism — ‘the autisms’ — and the many routes to a diagnosis of autism. What studying dietary intervention for autism suggests regarding metabolomics and the bigger picture of individualised autism science.

Handouts are online HERE

This is a joint presentation by ARI and The World Autism Organisation.

About the speaker:

Paul Whiteley, PhD has been involved in autism research for 25 years under the tutelage of Paul Shattock. He has worked at ESPA Research for 10+ years. Dr. Whitetely’s research interests include (i) the efficacy, safety and science behind dietary intervention for autism, (ii) the role of physical health and wellbeing in autism, and (iii) metabolomics and the potential for biological markers to aid early screening and timely diagnosis of autism and (iv) the pluralisation of autism (‘the autisms’).

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

  • pans/pots nutrition, autism related disorder

Food and Sleep

March 1st, 2022|Nutrition, Sleep, Ways to Help, Webinar|

Vicki Kobliner, RDN, CD-N, describes nutritional and lifestyle strategies for improving sleep and overall health for autistic people. She discusses circadian rhythm and balancing cortisol and melatonin cycles throughout the day.

The post Plural ‘Autisms’ and the Promises of Autism Metabolomics appeared first on Autism Research Institute.

]]>
TMS and Autism – 2021 Research Updates https://autism.org/tms-asd-2021/ Tue, 27 Apr 2021 21:50:24 +0000 https://last-drum.flywheelsites.com/?p=12732 Manuel Casanova, MD, discusses Transcranial Magnetic Stimulation and its potential for treating autism. He details the cerebral cortex development and notes revealed differences in mini-columnar morphology and gamma oscillations in individuals with autism. Casanova describes TMS treatments and outlines studies that correlated TMS sessions and increased cognitive abilities. He posits that TMS could shift

The post TMS and Autism – 2021 Research Updates appeared first on Autism Research Institute.

]]>

Manuel Casanova, MD, discusses Transcranial Magnetic Stimulation and its potential for treating autism. He details the cerebral cortex development and notes revealed differences in mini-columnar morphology and gamma oscillations in individuals with autism. Casanova describes TMS treatments and outlines studies that correlated TMS sessions and increased cognitive abilities. He posits that TMS could shift our focus from symptomatic treatments to interventions that target core pathologies of autism. Casanova notes that although evidence is hopeful, more research is needed to understand the scope and reach of TMS.

Take the knowledge quiz for this presentation HERE

Learn more about our speaker, Manuel Casanova, MD, HERE

In this presentation:

0:00 – First co-sponsored webinar with ARI and World Autism Organization
12:00 – Autism as a neurodevelopmental disease
16:20 – Development of cerebral cortex
19:50 – Disorders of neuronal migration in autism
20:35 – Study: Neuropathological markers in autism
21:10 – Mini-columns
23:09 – Compartmentalization of mini-columns in autism
24:57 – Shower Curtain of Inhibition|
27:58 – Study: Hat models of inhibitory deficit in autism
33:46 – Interneurons: Calcium-binding proteins
35:50 – PV-positive cells in controls and autism
38:00 – Implications of gamma oscillations in autism
41:10 – Gamma oscillations and EEGs
43:30 – TMS and Faraday’s Law
45:04 – Transcranial Magnetic Stimulation (TMS)
47:30 – TMS and the dorsolateral prefrontal cortex (DLPC)
47:53 – Clinical trial protocol and study design examples
50:29 – Effects of rTMS on gamma oscillations in autism and clinical significance
52:14 – Studies: 1) Post-TMS changes in response time and 2) Error rate and post-error rate improvement
55:40 – Heart Rhythm: Temporal and Frequency analysis
57:55 – Study: Effects of 18 TMS sessions on autonomic functions in ASD
59:20 – Studies: 1)TMS in autism: Repetitive and aberrant behaviors and 2) Effect of TMS sessions and behaviors
1:00:00 – Study: TMS in autism: Neurofeedback
1:01:00 – TMS in the public press
1:02:35 – Closing points
1:03:58 – Question & Answer session

Summary

Casanova begins by emphasizing that autism is a neurodevelopmental disorder. Therefore, he states, to create opportunities for curative treatments, we must first understand brain development and focus therapies on the pathology of autism (15:45). The presenter details the formation of the cerebral cortex (16:20) and how development differs in individuals with autism: 

  1. Neuroblasts (excitatory; precursor cells of neurons) and interneurons (inhibitory) migrate to the cortical plate (17:00)
  1.  Neuroblasts travel radially along arranged glial fibers
  2. Interneurons migrate tangentially (orthogonal to the glial fibers) 

Casanova highlights that the distance traveled by tangentially migrating neuroblasts is much greater than that of the radial pathway. Therefore, tangential migration expands the window of opportunity for disruption of neuroblast migration (16:20 – 21:15).  

  1. Mini columns (22:05) form at the joining of radial and tangential migratory currents in the cortical plate
    1. Cellular associations and functional exchanges between neurons and interneurons occur at the joining locations.
    2. When layered on top of one another, those cellular associations form the mini-column, a unit of anatomy and function (21:18).  

Post-mortem studies of mini-columnar morphometry in individuals with autism revealed a significantly reduced area in the peripheral neuronal space (23:20). Casanova emphasizes that the periphery of each mini-column is populated by inhibitory cells that help establish lateral inhibition (inhibition between adjacent columns) (23:52). He presents the analogy (26:45) of a bundle of conductive copper wires (neurons) where each wire is isolated from its neighbors by non-conductive material (interneurons). Deficient insulation (diminished inhibitory cells) allows the copper wires to touch, creating alternate paths for electricity flow (27:15) and a cascade of excitement across mini-columns (24:57)

  1. Synchronous recruitment of PV-positive interneurons generates rhythms of gamma oscillation important in cognitive task execution (38:00)
    1. PV-positive cells make up around 40% of all interneurons (34:48)
    2. Gamma oscillations help us construct a perception of reality based on the elements around us.  

Casanova outlines various studies that found a significant increase in gamma oscillatory activity in individuals with autism (50:29). These findings reflect a decrease in signal-to-noise ratio caused by a reduction in the total number of PV-positive cells or decreased inhibition (41:10). We can thus infer that “…the inhibitory cells in the periphery of the mini-column are diminished in number and function in individuals with autism…and that correcting this deficit could provide a therapeutic target in autism (24:30).” 

Transcranial Magnetic Stimulation (TMS) uses a polar magnetic field created from coiled conductors (43:30) to stimulate currents along the glial lines instead of through them (45:25). Due to the small magnetic field area, TMS can only treat specific parts of the brain (46:08). Because the dorsolateral prefrontal cortex (DLPC) interconnects with many brain areas, correcting inhibition deficits in this area could create a therapeutic cascade that could normalize the functionality of associations across the entire brain  (47:30)

Casanova outlines his research group studies that found direct relationships between TMS sessions and increased coherence of function across brain regions (51:02), improved error-rate and post-error response time (52:14), normalized autonomic nervous system parameters (57:55), and minimized abhorrent and repetitive behaviors (59:20). He posits that this type of therapy must be investigated as an alternative to neuroleptics as TMS has no known side effects (59:55).  

The presenter stresses that TMS should not be idealized as a possible cure for autism (1:01:00). Although the evidence is hopeful, he emphasizes the need for multi-center trials with sufficient participants to test the efficacy and compare TMS to other treatments and notes that long-term effects are not yet understood (1:02:35). Casanova outlines some of his latest publications before opening a question & answer session (1:03:58).

This is a joint presentation hosted by The World Autism Organization and ARI.

Manuel Casanova

Manuel Casanova, MD, served on the founding board of the National Alliance for Autism Research (now Autism Speaks) and the Autism Tissue Board. He has served on the Board of Directors or Scientific Advisory Board of numerous organizations including the Autism Research Institute. His research has been recognized by a EUREKA award from the NIMH for the introduction of repetitive Transcranial Magnetic Stimulation (rTMS) in the therapy of autism spectrum disorders.

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

The post TMS and Autism – 2021 Research Updates appeared first on Autism Research Institute.

]]>
Depression In ASD: Insights From A Network Analysis https://autism.org/depression-in-asd/ Tue, 12 Jan 2021 00:47:33 +0000 https://last-drum.flywheelsites.com/?p=12127 Depression as co-occurring condition in autism is frequently reported, but there is not a consensus on the risk factors. Tune in to learn about recent research on the inter-relationship between the two conditions and the clinical implications. Handouts are online HERE About the speaker:

The post Depression In ASD: Insights From A Network Analysis appeared first on Autism Research Institute.

]]>

Depression as co-occurring condition in autism is frequently reported, but there is not a consensus on the risk factors. Tune in to learn about recent research on the inter-relationship between the two conditions and the clinical implications.

Handouts are online HERE

About the speaker:

Farhad Montazeri M.D. conducts research in the field of Child Psychiatry, at Yale Child Study Center. He completed a Post Doctoral Fellowship in the field of Genetics at Yale University prior to his current affiliation with the Yale Child Study Center. His research is focused on Network Modeling of Psychiatric disorders, especially ASD, and its related comorbidities, like depression and anxiety. Dr. Montazeri’s network models are composed of interrelated phenotypical phenomena and, among others, they are used to study the (co)relationship between different manifestations of psychopathologies and their change at different states, for example in cases versus controls or before and after an intervention, etc.

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

  • pans/pots nutrition, autism related disorder

Food and Sleep

March 1st, 2022|Nutrition, Sleep, Ways to Help, Webinar|

Vicki Kobliner, RDN, CD-N, describes nutritional and lifestyle strategies for improving sleep and overall health for autistic people. She discusses circadian rhythm and balancing cortisol and melatonin cycles throughout the day.

The post Depression In ASD: Insights From A Network Analysis appeared first on Autism Research Institute.

]]>
Overview: Medical Comorbidities and ASD https://autism.org/unrecognized-medical-comorbidities-autism/ Mon, 04 Jan 2021 21:32:30 +0000 https://last-drum.flywheelsites.com/?p=12387 In this brief overview, neurologist Margaret Bauman, MD summarizes symptoms and signs of medical comorbidities that frequently occur, but may go unrecognized, in patients diagnosed with ASD. While the underlying cause of autism spectrum disorder (ASD) is generally unknown, scientists suspect that it is a multifactorial condition affecting multiple body systems. Margaret

The post Overview: Medical Comorbidities and ASD appeared first on Autism Research Institute.

]]>

In this brief overview, neurologist Margaret Bauman, MD summarizes symptoms and signs of medical comorbidities that frequently occur, but may go unrecognized, in patients diagnosed with ASD. While the underlying cause of autism spectrum disorder (ASD) is generally unknown, scientists suspect that it is a multifactorial condition affecting multiple body systems.

Margaret Bauman, MD, discusses medical comorbidities associated with autism and how they affect behavior and quality of life. She outlines some common physical comorbidities, including seizure (1:41), sleep (2:18), hormonal (2:47), urinary (3:00), and gastrointestinal (3:33) disorders, and details how these issues present differently in autistic individuals (1:30). Bauman describes our understanding of challenging behaviors in autism as a form of communication (1:00) and highlights the importance of knowing the signs (6:50).
Individuals with communication difficulties may not be able to describe what hurts or where (4:00). Similarly, sensory issues make it difficult for individuals to determine what is happening in their bodies (5:18). Therefore, Bauman recommends, “… individuals on the spectrum who demonstrate behavioral problems absolutely merit a good physical [and] medical workup (6:41)…. [and] gastrointestinal disorders… need to be one of the first areas of investigation (4:45).” She also suggests that providers who have experience working with individuals with autism be recruited to help create necessary interventions and best outcomes (7:46).

About the speaker:

Margaret Bauman, MD, is a pioneer in the study and treatment of Autism and is highly respected by her fellow clinicians and patients for the level of clinical care she provides and the advances that she has contributed to in the field. Dr. Bauman is a Neurologist and specializes in the diagnosis and treatment of Autism and various neurological disorders in children, adolescents, and adults to include learning and developmental disabilities, seizures, cerebral palsy, and neurogenetic disorders. Dr Bauman is the founding director of the LURIE CENTER, formally called LADDERS (Learning and Developmental Disabilities Evaluation and Rehabilitation Services). Dr. Bauman also established The Autism Research Foundation (TARF), The Autism Research Consortium (TARC), and The Autism Treatment Network (ATN). She has also made significant laboratory research contributions in the neuroanatomical understanding of Autism.

The post Overview: Medical Comorbidities and ASD appeared first on Autism Research Institute.

]]>
Autism: Multidisciplinary Evaluation and Treatment – The LADDERS Model https://autism.org/multidisciplinary-care/ Wed, 23 Sep 2020 01:26:01 +0000 https://last-drum.flywheelsites.com/?p=11126 Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by impaired social interaction, delayed and disordered communication skills and isolated areas of interest. There is a growing appreciation that ASD is more complex than previously recognized and in many cases, involves multiple organ systems beyond the brain. Those affected

The post Autism: Multidisciplinary Evaluation and Treatment – The LADDERS Model appeared first on Autism Research Institute.

]]>

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by impaired social interaction, delayed and disordered communication skills and isolated areas of interest. There is a growing appreciation that ASD is more complex than previously recognized and in many cases, involves multiple organ systems beyond the brain. Those affected require intensive therapeutic services as well as skilled medical diagnosis and supervision. This presentation describes a multidisciplinary clinical model in which the many services and interventions needed by ASD patients can be provided in a single site, thereby reducing fragmentation of care and providing skilled diagnostic care and ongoing supervision.

Handouts are online HERE

About the speaker:

Margaret Bauman, M.D., is a pioneer in the study and treatment of Autism and is highly respected by her fellow clinicians and patients for the level of clinical care she provides and the advances that she has contributed to in the field. Dr. Bauman is a Neurologist and specializes in the diagnosis and treatment of Autism and various neurological disorders in children, adolescents, and adults to include learning and developmental disabilities, seizures, cerebral palsy, and neurogenetic disorders. Dr Bauman is the founding director of the LURIE CENTER, formally called LADDERS (Learning and Developmental Disabilities Evaluation and Rehabilitation Services). Dr. Bauman also established The Autism Research Foundation (TARF), The Autism Research Consortium (TARC), and The Autism Treatment Network (ATN). She has also made significant laboratory research contributions in the neuroanatomical understanding of Autism.

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

Targeting Brain Plasticity in Autism using a Reading Intervention

September 26th, 2023|Autism Spectrum Disorders, Back to School, Biomarkers, Early Intervention, Educational Therapies, Ways to Help, Webinar|

Dr. Rajesh Kana considers the intersection of language comprehension, neuroplasticity, and autism interventions. He discusses contemporary research illustrating distinct patterns in autistic brain activity and underscores the importance of neuroplasticity

The post Autism: Multidisciplinary Evaluation and Treatment – The LADDERS Model appeared first on Autism Research Institute.

]]>
PANS/PANDAS in Children with Autism https://autism.org/pans-pandas-in-children-with-autism/ Wed, 26 Aug 2020 09:58:21 +0000 https://last-drum.flywheelsites.com/?p=8628 The information below is from the 2019 ARI webinar, PANS/PANDAS - Research Updates In rare cases, some children may experience the sudden onset of Obsessive-Compulsive Disorder or eating disorders. This pediatric acute-onset neuropsychiatric syndrome is commonly called PANS. PANDAS is a subtype of PANS with a specific known cause, exposure to a

The post PANS/PANDAS in Children with Autism appeared first on Autism Research Institute.

]]>

The information below is from the 2019 ARI webinar, PANS/PANDAS – Research Updates

In rare cases, some children may experience the sudden onset of Obsessive-Compulsive Disorder or eating disorders. This pediatric acute-onset neuropsychiatric syndrome is commonly called PANS. PANDAS is a subtype of PANS with a specific known cause, exposure to a strep infection. While PANS/PANDAS occurs mostly in children who do not also have Autism Spectrum Disorder, in rare cases, a child may have both conditions. Recognizing and diagnosing PANS/PANDAS in a child with ASD can be especially challenging because many of the symptoms overlap.

Signs and Symptoms of PANS/PANDAS

Between 1 and 3% of youths have OCD. Among children with OCD, up to 5% may meet the criteria for PANS/PANDAS. While as many as 17% of children with autism also have OCD, it is very rare that their OCD is linked to PANDAS. Even so, the situation can arise. When it does, it can be difficult to separate the symptoms of autism from signs of PANS/PANDAs since many of the symptoms and comorbidities overlap.

While PANS is a group of symptoms without an undetermined cause, PANDAS does have a clear trigger. In most cases, the onset of PANDAS is triggered by exposure to Group A Streptococci, commonly known as strep throat or a strep infection. Other microbes, including Lyme and Mycoplasma, may also be related to PANDAS. When a child with genetic susceptibility (2-5% of the population) is exposed to these microbes, it causes a misdirected immune response, which leads to brain inflammation. This can manifest as PANDAS. 

PANS/PANDAS, autism

PANS/PANDAS is marked by the abrupt onset of OCD or Anorexia. With the concurrent onset of at least two of seven signs:

  1. Anxiety
  2. Behavioral developmental regression
  3. Emotional liability or depression
  4. Irritability aggression or severally oppositional behavior
  5. Deterioration in school performance
  6. Sensory or motor abnormalities
  7. Somatic signs/symptoms, especially insomnia and urinary symptoms

PANDAS is essentially a form of autoimmune encephalitis, a complex set of brain disorders, characterized by autoimmune induced neuroinflammation. It is diagnosed only when symptoms are not better explained by other neurologic or medical disorders such as Sydenham’s chorea or Tourette Syndrome.

Who gets PANS/PANDAS?

By definition, PANS/PANDAS affects children. While it may be diagnosed in children between the ages of 3 and 12, the average age of onset is between 7 and 8 years old. It is most common in children between Kindergarten and second grade.

PANS/PANDAS seems to affect all socio-demographic groups equally. However, researchers have noticed increased rates of these conditions in families with a history of acute rheumatic fever or OCD. For a more in-depth look into the history and impacts of PANDAS, view the webinars Research Updates – PANS/PANDAS by Dr. Susan Swedo, who led the NIMH team that was first to identify this new subtype of pediatric OCD and and our latest webinar Systemic Inflammatory & Autoimmune Diseases—PANS  by Jennifer Frankovich, MD, MS.

Dr. Swedo describes comorbidities as a rule, rather than the exception, in children with PANDAS. Common Comorbidities include:

  • Sleep disorders (80%)
  • Behavioral regression (98%)
  • Inability to concentrate (90%)
  • Handwriting deterioration (90%)
  • Urinary frequency, urgency, enuresis (90%)

Only about 10% have hallucinations, and about 20% have eating disorders. More common comorbidities include short-term memory loss, hyperactivity, aggressiveness, learning difficulties, and sensory hypersensitivity.

How PANS/PANDAS is diagnosed

Diagnosis of PANS/PANDAS is based on the consensus statement from the PANS Consensus Conference, published in the Journal of Child and Adolescent Psychopharmacology in 2015. PANS/PANDAS requires a differential diagnosis, meaning that the symptoms cannot be better caused by another known medical or neurological disorder. Other diagnoses might include:

  • Lupus
  • Steroid responsive encephalitis
  • Multiple sclerosis
  • Guillain Barre syndrome
  • A different form of Autoimmune encephalitis
  • Other disorders

Before diagnosing PANDAS, a physician may order laboratory testing, EEG and MRI scans, or a sleep study. They will likely take a comprehensive family history (paying special attention to genetic factors and exposure to strep), perform a physical examination, and look for involuntary movements and dilation of the pupils. If the onset is recent, the clinician may also take a throat culture to identify the presence of a strep infection. Remember that PANDAS can only be diagnosed if the symptoms cannot be explained by another disorder. Clinicians should seek to rule out other illnesses first.

How is it treated

Clinicians generally take a three-prong approach to treating PANDAS.  

1. Treating and preventing infections: If the child has a bacterial infection, treating this infection can reduce symptoms and improve outcomes, especially during the first weeks or months of illness. In this case, a physician may prescribe 3 to 4 weeks of narrow-spectrum antibiotics.

2. Addressing immune system dysfunction: Immunomodulatory therapies to address immune system dysfunction may include NSAID’s Oral or IV steroids, intravenous immunoglobulin (IVIG), therapeutic plasmapheresis, and others indicated by severity. These are only useful in conjunction with infection treatment and psychiatric and behavioral interventions.

If a child has OCD but does not have PANS/PANDAS, there is no reason to pursue a long-term immune treatment. In a study by Nicolson et al, JAACAP 2000, children with OCD but without PANS/PANDAS saw no significant improvement from therapeutic plasma exchange. These therapies are expensive and intensive. Other studies have shown similar results.

3. Applying Behavioral and Psychiatric Interventions: Behavioral and psychiatric Interventions may include SSRI’s Anxiolytics, Soporifics, other typical psychiatric medications, and cognitive behavior therapy. When choosing a therapist, Dr. Swedo suggests looking for an expert in OCD treatment:

“If I had my choice between a therapist who had a lot of experience treating children or one who had a lot of experience treating OCD in adults, I would actually go for the treatment of OCD in adults because treatment of OCD in children is identical to that has been found to be effective for adult patients with obsessive-compulsive disorder,” she said.

Supportive therapy can help parents understand the course of illness and treatment. Getting parents into CBT even before the child is ready can be very helpful.

Treatments should be administered by a licensed and qualified healthcare provider. If you suspect your child may have PANS or PANDAS, consult your primary care physician.

In very rare cases, a child with autism may also qualify for a diagnosis of PANS/PANDAS. For a deeper look at the latest PANS/PANDAS research, view the webinar presented by Susan Swedo, M.D. and our latest webinar Systemic Inflammatory & Autoimmune Diseases—PANS  by Jennifer Frankovich, MD, MS.

For more information, visit the PANDAS Physicians Network.

ARI thanks Sue Swedo, MD, for her contributions to this article. 

  • autism comorbidities

Co-Occurring Conditions and Autism

January 10th, 2022|News, Uncategorized|

Research suggests that individuals with autism experience some conditions―including underlying medical issues, neurodevelopmental differences, and mental health issues―more frequently than the general population. Learning about these potential medical needs can help you

The post PANS/PANDAS in Children with Autism appeared first on Autism Research Institute.

]]>